MENU
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CRISPR Therapeutics AG (CRSP) Ownership - Who owns CRISPR Therapeutics AG?
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.84B
P/E Ratio
N/A
Total Cash
1.86B
Projected Growth
N/A
Total Debt
219.36M
Revenue
35M
Risk (Beta)
2.16
Dividend Yield
N/A
Total Cash/Share
21.48
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
Fundamentals
CRSP
Capitalization
4.84B
P/E Ratio
N/A
Risk (Beta)
2.16
Dividend Yield
N/A
Total Cash
1.86B
Total Cash/Share
21.48
Total Debt
219M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.41%
Revenue
35M
ROE
N/A
Book Value
1.83B
P/B Ratio
2.65
Cash Flow
N/A
Earnings
-4.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.72M
Current Ratio
15.64
Current Revenue Per Employee
89058.52
Dividends Per Share - Security
N/A
EBITDA
-455.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-16.75
Shares Held By Institutions
8.89B
Shares Outstanding - Current
86.4M
Total Liabilities
337M
Total Volume MTD
N/A
Value
-1
Gain YTD
42.937
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene-based medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com